181 related articles for article (PubMed ID: 2099845)
1. Monoclonal antibodies and tumor vaccines.
Ferrone S
Curr Opin Oncol; 1990 Dec; 2(6):1146-51. PubMed ID: 2099845
[No Abstract] [Full Text] [Related]
2. Anti-idiotypic tumor vaccines.
Hellström KE; Hellström I
Int Rev Immunol; 1989; 4(4):337-46. PubMed ID: 2519931
[No Abstract] [Full Text] [Related]
3. Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer.
Hanna MG; Howard J; Vermorken J
Hum Vaccin Immunother; 2014; 10(11):3286-96. PubMed ID: 25483649
[No Abstract] [Full Text] [Related]
4. Immunological approaches to tumor therapy. Monoclonal antibodies, tumor vaccines, and anti-idiotypes.
Hellström KE; Hellström I
Targeted Diagn Ther; 1989; 2():1-39. PubMed ID: 2519542
[No Abstract] [Full Text] [Related]
5. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
6. T cell-based immunotherapy for cancer: a virtual reality?
Lum LG
CA Cancer J Clin; 1999; 49(2):74-100, 65. PubMed ID: 11198889
[TBL] [Abstract][Full Text] [Related]
7. Human Tumor Antigens and Cancer Immunotherapy.
Vigneron N
Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
[TBL] [Abstract][Full Text] [Related]
8. [Antibody and immunotherapy in oncology. Which patients benefit?].
Schlimok G
MMW Fortschr Med; 2001 Jun; 143(25):24-8. PubMed ID: 11468992
[TBL] [Abstract][Full Text] [Related]
9. Adoptive cell therapy: past, present and future.
Cohen JE; Merims S; Frank S; Engelstein R; Peretz T; Lotem M
Immunotherapy; 2017 Jan; 9(2):183-196. PubMed ID: 28128715
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies in cancer immunotherapy.
Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C
Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129
[TBL] [Abstract][Full Text] [Related]
11. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
Castello G; D'Alessio V
Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084
[TBL] [Abstract][Full Text] [Related]
12. Tumor immunology.
Stevenson H; Tsang KY
Immunol Ser; 1993; 58():497-515. PubMed ID: 8424991
[No Abstract] [Full Text] [Related]
13. Future directions in tumor immunotherapy: CTLA4 blockade.
Gulley JL; Dahut WL
Nat Clin Pract Oncol; 2007 Mar; 4(3):136-7. PubMed ID: 17327854
[No Abstract] [Full Text] [Related]
14. Anti-idiotype vaccine against cancer.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
[TBL] [Abstract][Full Text] [Related]
15. Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapy.
Reisfeld RA; Cheresh DA
Cancer Surv; 1985; 4(1):271-90. PubMed ID: 3916082
[No Abstract] [Full Text] [Related]
16. [Cancer immunotherapy].
Vakkila J; Pihkala U
Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
[No Abstract] [Full Text] [Related]
17. Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors.
Ferrone S
Ann N Y Acad Sci; 1993 Aug; 690():214-24. PubMed ID: 8368740
[No Abstract] [Full Text] [Related]
18. Cancer Immunotherapy: Theory and Application.
Chen G; Bodogai M; Tamehiro N; Shen C; Dou J
J Immunol Res; 2018; 2018():7502161. PubMed ID: 30035133
[No Abstract] [Full Text] [Related]
19. Tumor immunology top 10 list.
Finn OJ
Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
[No Abstract] [Full Text] [Related]
20. [Cancer immunotherapy--current status].
Kundig TM; Renner Ch; Knuth A
Ther Umsch; 2006 Apr; 63(4):262-6. PubMed ID: 16689457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]